May 13th 2024
Physicians should consider the roles of verbal and ocular anesthesia.
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
The Ins and Outs of Lubricating Eye Drops
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Heading to AAO? You’re invited to a CME dinner. Or join virtually!
Date TBA
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
Could a multifocal IOL be the answer to patients' visual needs?
October 1st 2006The Tecnis multifocal IOL (Advanced Medical Optics) has been shown to be highly effective for patients with different clinical needs, such as in patients undergoing cataract surgery and IOL implantation, those with presbyopia, and in those with hyperopia. Three studies presented at the annual meeting of the American Society of Cataract and Refractive Surgery reported the results with this IOL.
Read More
Can cataract/refractive surgeons upgrade their customer service?
October 1st 2006Pleasanton, CA-Certain elements are key to building a successful lenticular refractive practice, according to Shareef Mahdavi, BA. While technology will continue to evolve, success with implants will likewise require physicians to evolve their approaches to the business side of refractive surgery, namely, upgrading their customer service.
Read More
Combination treatment may improve keratoconus/post-LASIK ectasia
October 1st 2006Minneapolis, MN-Early results are promising regarding the potential role of conductive keratoplasty (CK, Refractec) as an additional tool to improve vision outcomes in eyes with keratoconus or post-LASIK ectasia treated with corneal implants (Intacs, Addition Technology), said Jason K. Darlington, MD.
Read More
Aggressive treatment aids in corneal transplant rejection
October 1st 2006Cincinnati-"Regardless of whether we are talking about full-thickness transplants or endothelial transplants, corneal transplant rejection is the leading cause of graft failure," said Edward J. Holland, MD, director, Cornea and External Diseases, Cincinnati Eye Institute, Cincinnati.
Read More
Could a multifocal IOL be the answer to patients' visual needs?
October 1st 2006The Tecnis multifocal IOL (Advanced Medical Optics) has been shown to be highly effective for patients with different clinical needs, such as in patients undergoing cataract surgery and IOL implantation, those with presbyopia, and in those with hyperopia. Three studies presented at the annual meeting of the American Society of Cataract and Refractive Surgery reported the results with this IOL.
Read More
Accommodating IOL design modification reduces PCO
October 1st 2006Los Angeles-Preliminary results from a prospective study of patients with the crystalens square edge (SE) accommodating IOL (eyeonics) implanted suggest modification of the original optic edge design has been effective for reducing the development of posterior capsule opacification (PCO) and without causing an increase in visual quality-related complaints, according to D. Michael Colvard, MD.
Read More
Improving blepharoplasty results with careful observation
October 1st 2006Baltimore-Surgical results for patients requesting a blepharoplasty can be improved if the surgeon carefully examines individuals for coexisting diagnoses, pre-existing asymmetries, brow position, and lower eyelid malposition, explained Shannath L. Merbs, MD, PhD, FACS.
Read More
Tunnel creation examined as another femtosecond laser application
October 1st 2006Baltimore-Tunnel creation for placement of corneal implants (Intacs, Addition Technology) in eyes with corneal ectasia is a promising new use for the femtosecond laser (IntraLase FS, IntraLase), according to Alisa Kim, MD.
Read More
Botulinum toxin gains popularity for variety of disorders
September 15th 2006The use of botulinum toxin by ophthalmologists to treat a variety of disorders has exploded over the past several years. It has highlighted many issues of interest, including off-label use, supply charges, and cosmetic indications. All of these have important implications for coding, billing, and reimbursement.
Read More
Initial experience good with accommodating IOL
September 15th 2006San Francisco-In an initial analysis, the Synchrony dual-optic single-piece IOL (Visiogen) performed well. The visual results were good, there were no major complications and no glare or halos after implantation, and patient satisfaction was high, according to George Beiko, BM, BCh, FRCS.
Read More
Clear corneal incisions and silicon IOLs new endophthalmitis risk factors
September 11th 2006Clear corneal incisions and silicon IOLs are new risk factors in post-cataract surgery endophthalimitis, Peter Barry revealed in the first presentation of the full ESCRS endophthalmitis study results.
Read More
Blue light-blocking IOLs unnecessary
September 10th 2006There is no current proof that blocking blue wavelengths guarantees retinal protection and, couple this with the fact that blocking this form of light causes an actual loss in visual quality, Alessandro Franchini MD, suggests we concentrate our efforts on blocking UV and violet radiations instead.
Read More
Good pseudoaccommodation with MICS lens at one year
September 9th 2006The new MICS lens (Ioltech-Zeiss) is appropriate for the correction of intermediate vision in pseudophakia, according to Carlos Verges, Jorge Cazal and Marc Menezo of the Department of Ophthalmology, Institut Universitari Dexeus, Barcelona, Spain.
Read More
Drainage devices useful for refractory disease
September 1st 2006Fort Lauderdale, FL-The B?rveldt-250 mm2 Glaucoma Implant (Advanced Medical Optics) seems to be more effective at lowering IOP than the Ahmed S2 Glaucoma Valve (New World Medical Inc.) in adult patients with refractory glaucoma. However, regardless of which of the devices is implanted, the preoperative IOP is a risk factor for eventual failure, according to Darrell WuDunn, MD, PhD, and colleagues, who presented their findings at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
Lenstec sales office opens in Barcelona
September 1st 2006St. Petersburg, FL-Lenstec Inc. opened a new Barcelona sales office to help the company meet growing European demand for its lens implants and devices used in cataract and refractive surgery. With a sales and marketing office in Yorkshire, England, this move expands Lenstec's European operations.
Read More
More than 50,000 crystalenses implanted
September 1st 2006Aliso Viejo, CA-Since FDA approval in 2003, more than 50,000 crystalens accommodating IOLs (eyeonics) have been implanted worldwide. Of these, 17,000 implants were with the crystalens SE second-generation lens (introduced in 2005), the company said in a prepared statement.
Read More
Modified glaucoma value reduces outflow resistance
September 1st 2006Fort Lauderdale, FL-A modified glaucoma valve made of a porous polymer material reduced outflow resistance in tests conducted in an animal model. The reduced resistance should in turn result in improved control of IOP over conventional implants, explained R. Rand Allingham, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
SLT may be useful as primary glaucoma therapy
September 1st 2006London, Ontario-During at least the first 12 months after treatment initiation, selective laser trabeculoplasty (SLT) and latanoprost 0.005% (Xalatan, Pfizer) are associated with equivalent efficacy and safety profiles when used as primary therapy for newly diagnosed open-angle glaucoma or ocular hypertension, according to the results of a prospective, multicenter, parallel comparison, clinical trial conducted by researchers at Ivey Eye Institute, University of Western Ontario, London.
Read More
Pain control, relief key to outpatient enucleation surgery
August 1st 2006Baltimore-Significant postoperative pain can occur after enucleation surgery. Multimodal anesthesia, combining oral agents and a local anesthetic, can provide superior pain relief, according to Shannath L. Merbs, MD, PhD, FACS, associate professor of ophthalmology and oncology, Wilmer Eye Institute and Johns Hopkins University School of Medicine, Baltimore.
Read More
Alcon IOL receives NTIOL designation
August 1st 2006Fort Worth, TX-The Centers for Medicare and Medicaid Services' (CMS) New Technology Intraocular Lens (NTIOL) classification of Reduced Spherical Aberration has been applied to the AcrySof IQ IOL (Alcon Laboratories). The IOL gained inclusion by proving the same or greater clinical benefit as the lens that established the NTIOL subset, according to Alcon Laboratories.
Read More
Pain control, relief key to outpatient enucleation surgery
August 1st 2006Baltimore-Significant postoperative pain can occur after enucleation surgery. Multimodal anesthesia, combining oral agents and a local anesthetic, can provide superior pain relief, according to Shannath L. Merbs, MD, PhD, FACS, associate professor of ophthalmology and oncology, Wilmer Eye Institute and Johns Hopkins University School of Medicine, Baltimore.
Read More
Dispelling some common myths of ophthalmic surgery billing
July 15th 2006Dorado, Puerto Rico-Make sure that your billing department is aware of common myths associated with ophthalmic surgery billing, so that surgery claims being filed are correct, advised Donna M. McCune, CCS-P, COE, who spoke during Current Concepts in Ophthalmology.
Read More
Surgeon incorporates slit lamp exam as part of TASS protocol
July 15th 2006Los Alamitos, CA-Larry Geisse, MD, a surgeon in private practice in Los Alamitos, CA, recently encountered a case of toxic anterior segment syndrome (TASS) that might hold lessons for other clinicians in the treatment of TASS.
Read More
Dislocation, decentration concerns for foldable IOLs, survey finds
July 15th 2006San Francisco-The most common complications involving foldable IOLs and requiring explantation showed little change over the past 2 years, according to an annual survey sent to members of the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS).
Read More